Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1042.9000 4.10 (0.39%)

NSE Apr 02, 2026 15:31 PM

101.47% Gain from 52W Low

Volume: 2.9M

Laurus Labs Ltd.

25 Apr 2025

1042.90

0.39%

Laurus Labs (HOLD): Visibility of Operating Leverage

Hold: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Revenue/EBITDA/PAT exceeded our estimates by 8.4%/32.6%/110.3%; EBITDA margin surpassed our estimate by 440 bps

Motilal Oswal released a Buy report for Laurus Labs Ltd. with a price target of 1280.0 on 19 Mar, 2026.